Try our Advanced Search for more refined results
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA v. FEDERAL TRADE COMMISSION
Case Number:
1:13-cv-01974
Court:
Nature of Suit:
Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
Government Agencies
Sectors & Industries:
-
June 02, 2014
FTC's Pharma Patent Regulations Upheld
A D.C. federal judge on Friday sided with the Federal Trade Commission in a dispute over whether it was allowed to require drugmakers to report more exclusive patent licenses for approval under federal merger law.
-
March 25, 2014
PhRMA Slams FTC's Rationale For Targeting Drugmakers
The Pharmaceutical Research and Manufacturers of America on Monday blasted the Federal Trade Commission's argument that the agency has authority to issue industry-specific requirements and urged a D.C. federal judge to vacate a rule requiring pharmaceutical companies to report more exclusive patent licenses for approval under federal merger law.
-
March 11, 2014
FTC Says It Can Place HSR Act Restrictions On Drug Cos.
The Federal Trade Commission said Monday it has the authority to issue reporting requirements that impact just the pharmaceutical industry, and asked a Washington, D.C., federal judge to rule in its favor in a dispute over patent licenses with the Pharmaceutical Research and Manufacturers of America.
-
February 10, 2014
PhRMA Moves To Vanquish FTC Rule Targeting Drugmakers
The Pharmaceutical Research and Manufacturers of America on Friday urged a D.C. federal judge to vacate a Federal Trade Commission rule requiring pharmaceutical companies to report more exclusive patent licenses for antitrust approval under federal merger law, arguing that the agency lacks the authority to target specific sectors.